Form 4: Intuitive Surgical Executive Brosius Sells Shares Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Mfg and Supply Chain Officer at Intuitive Surgical, sold 2,115 shares of common stock on September 12, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On September 12, 2024, Mark Brosius, an officer at Intuitive Surgical, sold 2,115 shares of the company's common stock.
• The sale was executed under a pre-existing trading plan that complies with SEC Rule 10b5-1, set to expire on June 13, 2025.
• The price per share for the sale was $491.91.
• Following the transaction, Brosius directly owns 295 shares of Intuitive Surgical common stock.
• Brosius also exercised a non-qualified stock option for 2,115 shares at a price of $59.4622.
• The stock option was granted under the 2010 Incentive Award Plan and vests over time.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Positives

• The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on insider information.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options and restricted stock units to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to sell company stock in a predetermined manner, mitigating the risk of insider trading allegations.
• Comparing Brosius's stock sales to those of executives at similar companies like Medtronic or Stryker could provide a benchmark for assessing the magnitude and frequency of insider transactions.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates